Ocular Therapeutix Reports Third Quarter 2016 Financial Results and Provides Corporate Update Biotech Investing
Marapharm Discusses the "Yes" Result of the Nevada Marijuana Legalization Initiative Biotech Investing
DBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients Biotech Investing
